Matsumoto S¹, Watanabe M¹, Hashizume K¹, Wada N¹, Hori J¹, Kita M¹, Iwata T¹, Kakizaki H¹
1. Department of Renal and Urologic Surgery, Asahikawa Medical University
Animal Study, Basic Science, Bladder Outlet Obstruction , Physiology, Voiding Dysfunction

Kiuchi H¹, Tsujimura A¹, Takezawa K¹, Okuda H¹, Fukuhara S¹, Takao T¹, Miyagawa Y¹, Nonomura N¹, Adachi M², Nomura T²
1. Osaka University Graduate School of Medicine, 2. National Institute of Biochemical Innovation
Benign Prostatic Hyperplasia (BPH), Basic Science, Other [PDE-5 inhibitor]

Kanno Y¹, Mitsui T¹, Kitta T¹, Moriya K¹, Tsukiyama T², Hatakeyama S², Nonomura K¹
1. Department of Urology Hokkaido University Graduate School of Medicine, 2. Department of Biochemistry Hokkaido University Graduate School of Medicine
Bladder Outlet Obstruction , Molecular Biology, Physiology, Voiding Dysfunction , Pathophysiology

Cho K J¹, Kim S D², Seo J T³, Kim S H¹, Kim J C¹
1. The Catholic University of Korea, College of Medicine, 2. Jeju National University, School of Medicine, 3. Cheil General Hospital, Kwandong University, College of medicine
Detrusor Overactivity, Pathophysiology, Basic Science

Flugel R¹, Paborji M¹, Duchin K¹, Tremblay T¹, Dmochowski R², Staskin D³
1. TheraVida, 2. Vanderbilt University, 3. Tufts University
Detrusor Overactivity, Overactive Bladder, Pharmacology, Urgency Urinary Incontinence, Urgency/Frequency

Castro Díaz D¹, Chapple C², Hakimi Z³, Blauwet M B⁴, Delgado-Herrera L⁴, Fitzsimmons W⁴, Lau W⁴, Mujais S⁴
1. University Hospital Canary Islands, 2. Royal Hallamshire Hospital, Department of Urology, Sheffield, UK, 3. Astellas Pharma Europe Ltd, 4. Astellas Pharma Global Development, Inc
Clinical Trial, Incontinence, Outcomes Research Methods, Overactive Bladder, Quality of Life (QoL)

Abrams P¹, Kelleher C², Staskin D³, Kay R⁴, Martina R⁵, Newgreen D⁵, Paireddy A⁵, van Maanen R⁵, Ridder A⁵
1. Bristol Urological Institute, Bristol, UK, 2. Guy's and St Thomas’ NHS Foundation Trust, London, UK, 3. Tufts U School of Medicine, Boston, MA, USA, 4. RK Statistics Ltd, Bakewell, UK, 5. Astellas Pharma BV, Leiden, the Netherlands
Overactive Bladder, Incontinence, Clinical Trial

Bosman B¹, Tannenbaum S², Winklewski P¹, Den Adel M¹, Newgreen D¹, Baka-Ostrowska M³
1. Astellas Pharma Europe B.V., 2. Astellas Pharma US B.V., 3. Pomnik-Centrum Zdrowia Dziecka Warsaw
Pediatrics, Clinical Trial, Detrusor Overactivity